Schulz KF, Grimes DA, 2002: Blinding in randomisedtrials: hiding who got what, Lancet, vol 3599307, pg 696 700. Thorpe KE, Zwarenstein M, Oxman AD, Treweek S, Furberg CD,Altman DG, Tunis S, Bergel E, Harvey I, Magid DJ, Chalkidou K, 2009: Apragmatic explanatory continuum indicator summary PRECIS: program engineering tool to helptrial designers, Journal coding help Clinical Epidemiology, vol 625,pg 464 475. Tudur Smith C, Hickey H, Clarke M, Blazeby J, Williamson P,2014: programming help trials methodological analysis agenda: results from software engineering prioritysetting endeavor Trials, vol 151, pg 32. Villanueva C, Colomo A, Bosch A, Concepcion M, Hernandez GeaV, Aracil C, Graupera I, Poca M, Alvarez Urturi C, Gordillo J, Guarner ArgenteC, Santalo M, Muniz E, Guarner C, 2013: Transfusion ideas for acuteupper gastrointestinal bleeding, N Engl J Med, vol 3681 ,pg 11 21. Wright S, Duncombe P, Altman DG, 2012: Assessment ofblinding to cure allocation in reports coding help application engineering hashish based medicineSativex R in individuals with multiple sclerosis: application engineering new strategy, Trials, vol13, pg 189. Wood L, Egger M, Gluud LL, Schulz KF, Juni P, Altman DG,Gluud C, Martin RM, Wood AJ, Sterne JA, 2008: Empirical facts coding help biasin cure effect estimates in managed trials with different interventionsand effects: meta epidemiological study, BMJ, vol 3367644,pg 601 605.